Patents by Inventor Roland Blanque

Roland Blanque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATMENT OF MUSCULAR DYSTROPHIES
    Publication number: 20190167640
    Abstract: The present invention relates to, inter alia, treatment of muscle dystrophy (e.g., Duchenne Muscular Dystrophy), for example, using a composition, e.g., a composition comprising Compound (I), or a pharmaceutically acceptable salt, prodrug or metabolite thereof.
    Type: Application
    Filed: October 24, 2018
    Publication date: June 6, 2019
    Inventors: Ernest D. Bush, Francois Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanque, Jean-Michel Lefrancois, Christophe Peixoto, Pierre Deprez, Nicholas Triballeau, Piet Tom Burt Paul Wigerinck
  • METHODS FOR TREATMENT OF MUSCULAR DYSTROPHIES
    Publication number: 20160250188
    Abstract: The present invention relates to, inter alia, treatment of muscle dystrophy (e.g., Duchenne Muscular Dystrophy), for example, using a composition, e.g., a composition comprising Compound (I), or a pharmaceutically acceptable salt, prodrug or metabolite thereof.
    Type: Application
    Filed: October 24, 2014
    Publication date: September 1, 2016
    Inventors: Ernest D. Bush, Francois Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanque, Jean-Michel Lefrancois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Burt Paul Wigerinck
  • Imidazolidine compounds as androgen receptor modulators
    Patent number: 8383608
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: February 26, 2013
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck
  • NOVEL IMIDAZOLIDINE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20120178718
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3aR3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Application
    Filed: June 23, 2011
    Publication date: July 12, 2012
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck
  • Imidazolidine compounds as androgen receptor modulators
    Patent number: 7968581
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: June 28, 2011
    Assignee: Galapagos NV
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck
  • NOVEL IMIDAZOLIDINE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20100113547
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Application
    Filed: September 10, 2009
    Publication date: May 6, 2010
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck